Influenza virus

The Centre de Recerca en Sanitat Animal (CReSA) is the animal health research program of the Institut de Recerca i Tecnologia Agroalimentàries (IRTA), a public company of the Autonomous Government of Catalonia (Spain). CReSA is located at the campus of the Universitat Autònoma de Barcelona (UAB), working in a new and technologically advanced building with conventional laboratories as well as biocontainment with level-3 biosecurity (BSL3) laboratories and animal facilities. The mission of CReSA is to contribute to the advancement of scientific and technical knowledge on animal health by means of research, knowledge transfer and services to public and private bodies. The long term objective is to globally improve all aspects of animal health that influence the agri-food sector and public health. CReSA researchers’ expertise includes pathology, immunology, bacteriology, virology, entomology, epidemiology and molecular biology, as well as disease animal models. Viral research is focused on endemic and exotic viruses affecting mainly livestock (swine, ruminants and poultry) and occasionally wildlife. Zoonotic viruses including animal influenza viruses, West Nile virus, Rift Valley fever virus and MERS-coronavirus are nowadays significant poles of research.

The Microbiology, Immunology and Pathology (MIP) Department is comprised of over 400 individuals who share a common passion for solving some of the most important human and animal health problems today. Research programs include those related to mycobacteria, retroviruses, prions, and arthropod-borne infectious diseases, as well as the diagnostic investigation of naturally-occurring animal diseases. A leader in education, MIP provides the only microbiology undergraduate degree program in Colorado, a graduate program that provides training in a number of cutting-edge disciplines, and several specialized veterinary residency training programs.

The CWOHC provides a unique opportunity for UW, Colombian, and international institutions to demonstrate leadership and have an impact in viral diseases affecting both human and animal health in Latin American countries. Professor Osorio is a global expert on the study of emerging viral diseases and has conducted field and laboratory studies on many emerging pathogens, including dengue, Zika, chikungunya, influenza, rabies, west Nile, enteroviruses, monkeypox among others. The Universidad Nacional (UN) is ranked among the best universities in the region and is committed to be among the best 100 institutions of higher education in the world. It has approximately 100,000 students, with 7 campuses located in different regions of the country. Added to the trajectory of quality and excellence of the University of Wisconsin-Madison and to the support for innovation and leadership given by the Ruta N Corporation, it is expected that, in this Consortium, generation of knowledge will be greatly promoted.

The MRC-University of Glasgow Centre for Virus Research (CVR) represents the UK’s largest grouping of human and veterinary virologists. More than 20 principal investigators and their associated teams make up the research core of the CVR creating a critical mass of researchers dedicated to the study of human and animal viral diseases. We carry out multidisciplinary research on viruses and viral diseases, translating the knowledge gained for the improvement of health and benefit of society. Research at the CVR spans molecular, structural and cellular levels through to the individual host and affected population, thus integrating molecular and structural virology, cell biology, pathogenesis, epidemiology and mathematical modelling. Our research covers emerging viruses including arboviruses, innate and intrinsic immunity to virus infection, hepatitis C virus, viruses and cancer, structural virology, viral genomics and bioinformatics.

Originally founded in 1892, the National Institute of Infectious Diseases aims at carrying out extensive and original research projects on a variety of contagious diseases from the standpoint of preventive medicine, improving human health and welfare by suppressing infectious diseases, and clarifying and supporting the scientific background of health and medical administration of the government. These functions may be summarized into 1) research activities, 2) reference services for infectious diseases, 3) surveillance of infectious diseases, 4) national control tests and other tests, 5) international cooperation, and 6) training activities.

The Wyss Institute for Biologically Inspired Engineering at Harvard University creates transformative technological breakthroughs by engaging in high-risk research, crossing disciplinary and institutional barriers, to develop new engineering solutions for healthcare, energy, architecture, robotics, and manufacturing. Our technologies are translated into commercial products and therapies through collaborations with clinical investigators, corporate alliances, and formation of new startups

The Division of Infectious Diseases at the University of Michigan was founded in 1958. Since then, the division has become recognized nationally for an exemplary record of patient care, research and teaching. In addition to the regular Infectious Diseases Outpatient Service, an Immunization and Overseas Travel Consultation Service is available for consultation, general health advice, and immunizations for both domestic and international travel. The University of Michigan Health System is among the best in the world, ranked in the top 15 health systems in the country in the most recent U.S. News and World Report. The Department of Internal Medicine consists of over 600 full time academic faculty, and is ranked fourth in the country in NIH research dollars.

Over the last five years, the URMC has garnered more than $1.18 billion in biomedical research funding, common and rare illnesses, landing the University in the top 26th percentile of U.S. medical centers in Federal research funding. Coupled with one million square feet of state-of-the-art research space, and high-end support services and shared resources, we’re building upon this strong legacy of research every day. Our scientists contributed vaccine technology: HPV vaccine, protecting against cervical cancer, newborns worldwide receive a vaccine that URMC researchers created against Haemophilus influenza type B (Hib), virtually wiping out a leading cause of meningitis in preschoolers. And we conducted the first pivotal, H5N1 bird flu efficacious and safety study, and ready to administer if faced with a pandemic. The Medical Center also has a long history in HIV research, being one of the first sites in the United States to conduct HIV vaccine studies. The NIH-sponsored University of Rochester HIV/AIDS Clinical Trials Unit, or The Rochester Victory Alliance, participated in more than 275 HIV treatment and vaccine trials, enrolling upwards of 3,500 volunteers since 1987.